Investigating prostate cancer tumour-stroma interactions: Clinical and biological insights from an evolutionary game

British Journal of Cancer

Volumn 106, Issue 1, 2012, Pages 174-181

  Basanta, D ^a   Scott, J G ^a   Fishman, M N ^a   Ayala, G ^b   Hayward, S W ^c   Anderson, A R A ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

evolutionary game theory; metastasis; prostate cancer; somatic evolution; therapy

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER INHIBITION; CANCER SURVIVAL; CELL INVASION; CELL MOTILITY; ENVIRONMENT; EPIGENETICS; GAME; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION; STROMA CELL; TUMOR CELL; TUMOR MICROENVIRONMENT;

BIOLOGICAL EVOLUTION; HUMANS; MALE; MODELS, THEORETICAL; PROSTATIC NEOPLASMS; STROMAL CELLS;

EID: 84855352011     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.517     Document Type: Article

References (42)

1. Anderson AR, Hassanein M, Branch KM, Lu J, Lobdell NA, Maier J, Basanta D, Weidow B, Narasanna A, Arteaga CL, Reynolds AB, Quaranta V, Estrada L, Weaver AM (2009) Microenvironmental independence associated with tumor progression. Cancer Res 69(22): 8797-8806
2. Ao M, Franco OE, Park D, Raman D, Williams K, Hayward SW (2007) Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res 67(9): 4244-4253 (Pubitemid 46815071)
3. Ao M, Williams K, Bhowmick NA, Hayward SW (2006) Transforming growth factor-promotes invasion in tumorigenic but not in nontumori-genic human prostatic epithelial cells. Cancer Res 66(16): 8007-8016 (Pubitemid 44299165)
4. Ayala GE, Muezzinoglu B, Hammerich KH, Frolov A, Liu H, Scardino PT, Li R, Sayeeduddin M, Ittmann MM, Kadmon D, Miles BJ, Wheeler TM, Rowley DR (2011) Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens. Am J Pathol 178(1): 79-87
5. Ayala G, Tuxhorn JA, Wheeler TM, Frolov A, Scardino PT, Ohori M, Wheeler M, Spitler J, Rowley DR (2003) Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. Clin Cancer Res 9(13): 4792-4801 (Pubitemid 37323282)
6. Balkwill F (2009) Tumour necrosis factor and cancer. Nat Rev Cancer 9(5): 361-371
7. Barclay WW, Woodruff RD, Hall MC, Cramer SD (2005) A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. Endocrinology 146(1): 13-18 (Pubitemid 40051716)
8. Basanta D, Scott JG, Rockne R, Swanson KR, Anderson AR (2011) The role of IDH1 mutated tumour cells in secondary glioblastomas: an evolutionary game theoretical view. Phys Biol 8(1): 015016
9. Basanta D, Simon M, Hatzikirou H, Deutsch A (2008) Evolutionary game theory elucidates the role of glycolysis in glioma progression and invasion. Cell Prolif 41(6): 980-987
10. Bellomo N, Chaplain M, De Angelis E (2008) Selected Topics in Cancer Modeling. Genesis, evolution immune competition, and therapy, Birkhauser. ISBN: 0817647120, 9780817647124
11. Bierie B, Moses HL (2006) Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6(7): 506-520 (Pubitemid 43980540)
12. Bishop DT, Cannings C (1978) A generalized war of attrition. J Theor Biol 70(1): 85-124
13. Blumberg JM, Kwon EO, Cheetham TC, Niu F, Shapiro CE, Pacificar J, Loo RK, Williams SG, Chien GW (2011) Early development of castrate resistance varies with different dosing regimens of luteinizing hormone releasing hormone agonist in primary hormonal therapy for prostate cancer. Urology 77(2): 412-416
14. Crespi B, Summers K (2005) Evolutionary biology of cancer. Trends Ecol Evol 20(10): 545-552 (Pubitemid 41323711)
15. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Grönberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG (2007) Inflammation in prostate carcinogenesis. Nat Rev Cancer 7(4): 256-269 (Pubitemid 46486616)
16. Diel IJ, Jaschke A, Solomayer EF, Gollan C, Bastert G, Sohn C, Schuetz F (2008) Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-up. Ann Oncol 19(12): 2007-2011
17. Dingli D, Chalub FA, Santos FC, Van Segbroeck S, Pacheco JM (2009) Cancer phenotype as the outcome of an evolutionary game between normal and malignant cells. Br J Cancer 101(7): 1130-1136
18. Franco OE, Jiang M, Strand DW, Peacock J, Fernandez S, Jackson II RS, Revelo MP, Bhowmick NA, Hayward SW (2011) Altered TGF-b signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis. Cancer Res 71(4): 1272-1281
19. Gallo M, De Luca A, Lamura L, Normanno N (2011) Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancer. Ann Oncol; e-pub ahead of print 12 May 2011; doi: 10.1093/annonc/mdr159
20. Gatenby RA, Vincent TL (2003) An evolutionary model of carcinogenesis. Cancer Res 63(19): 6212-6220 (Pubitemid 37255166)
21. He Y, Franco OE, Jiang M, Williams K, Love HD, Coleman IM, Nelson PS, Hayward SW (2007) Tissue-specific consequences of cyclin D1 over-expression in prostate cancer progression. Cancer Res 67(17): 8188-8197 (Pubitemid 47395155)
22. Hofbauer J, Sigmund K (1998) Evolutionary Games and Population Dynamics. Cambridge University Press: Cambridge
23. Kiskowski MA, Jackson II RS, Banerjee J, Li X, Kang M, Iturregui JM, Franco OE, Hayward SW, Bhowmick NA (2011) Role for stromal heterogeneity in prostate tumorigenesis. Cancer Res 71(10): 3459-3470
24. Kundu JK, Surh YJ (2008) Inflammation: gearing the journey to cancer. Mutat Res 659(1-2): 15-30
25. Lynch CC, Hikosaka A, Acuff HB, Martin MD, Kawai N, Singh RK, Vargo-Gogola TC, Begtrup JL, Peterson TE, Fingleton B, Shirai T, Matrisian LM, Futakuchi M (2005) MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell 7(5): 485-496 (Pubitemid 40719131)
26. Mansury Y, Diggory M, Deisboeck TS (2006) Evolutionary game theory in an agent-based brain tumor model: exploring the 'Genotype-Phenotype' link. Bull Math Biol 238(1): 146-156 (Pubitemid 41737803)
27. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203): 436-444
28. Merlo LM, Pepper JW, Reid BJ, Maley CC (2006) Cancer as an evolutionary and ecological process. Nat Rev Cancer 6(12): 924-935 (Pubitemid 44862677)
29. Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, Cook K, Stepansky A, Levy D, Esposito D, Muthuswamy L, Krasnitz A, McCombie WR, Hicks J, Wigler M (2011) Tumour evolution inferred by single-cell sequencing. Nature 472(7341): 90-94
30. Nowell P (1976) The clonal evolution of tumor cell populations. Science 194(4260): 23-28
31. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59(19): 5002-5011 (Pubitemid 29472907)
32. Reedy J (1975) Galen on cancer and related diseases. Clio Med 10(3): 227-238
33. Schayowitz A, Sabnis G, Goloubeva O, Njar VC, Brodie AM (2010) Prolonging hormone sensitivity in prostate cancer xenografts through dual inhibition of AR and mTOR. Br J Cancer 103(7): 1001-1007
34. Schetter AJ, Heegaard NH, Harris CC (2010) Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 31(1): 37-49
35. Schor SL, Schor AM, Howell A, Crowther D (1987) Hypothesis: persistent expression of fetal phenotypic characteristics by fibroblasts is associated with an increased susceptibility to neoplastic disease. Exp Cell Biol 55(1): 11-17 (Pubitemid 17044574)
36. Schor SL, Schor AM, Rushton G (1988) Fibroblasts from cancer patients display a mixture of both foetal and adult-like phenotypic characteristics. J Cell Sci 90(Pt 3): 401-407
37. Schor SL, Schor AM (1987) Clonal heterogeneity in fibroblast phenotype: implications for the control of epithelial-mesenchymal interactions. BioEssays 7(5): 200-204
38. Sigmund K, Nowak MA (1999) Evolutionary game theory. Curr Biol 9(14): R503-R505 (Pubitemid 29350840)
39. Smith JM (1982) Evolution and the Theory of Games. Cambridge University Press: Cambridge, UK
40. Strand DW, Franco OE, Basanta D, Anderson AR, Hayward SW (2010) Perspectives on tissue interactions in development and disease. Curr Mol Med 10(1): 95-112
41. Tomlinson IP, Bodmer WF (1997) Modelling the consequences of interactions between tumour cells. Br J Cancer 75(2): 157-160 (Pubitemid 27019555)
42. Yanagisawa N, Li R, Rowley D, Liu H, Kadmon D, Miles BJ, Wheeler TM, Ayala GE (2007) Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy. Hum Pathol 38(11): 1611-1620 (Pubitemid 47589095)